Aim: To investigate the current status and factors influencing fear of cancer recurrence (FCR) related to malignant bone-tumors in adolescent patients. Design: A cross-sectional survey. Methods: In total, 269 adolescent malignant-bone tumor cases were treated at two hospitals in Zhejiang Province, China from January 2023to December2023. Patients completed a General Information Questionnaire, Fear of Progression Questionnaire-Short Form (FoP-Q-SF), Family Hardiness Index (FHI), and a Simple Coping Style Questionnaire (SCSQ). Results: The total FoP-Q-SF score for adolescent malignant-bone tumorpatients was 33.07 ± 5.85, with 122 (45.4%) patients scoring ≥ 34; the FHI score was 57.88 ± 5.01; and the total SCSQ score was 32.14 ± 3.43. Pearson’s correlation analyses showed that family resilience and positive coping negatively affected FoP in patients, with total effect values of -0.559 and -0.468 (P < 0.001), respectively, and negative coping positively affected FoP in patients, with a total effect value of 0.483 (P < 0.001). Multiple linear regression analyses showed that per capita-monthly family income, disease duration, tumor stage, family hardiness, a positive coping score, and a negative coping score were the main factors influencing FCR in these patients (P < 0.05). Conclusions: FCR in malignant-bone tumor adolescent patients is profound. Healthcare professionals should develop targeted interventional strategies based on the identified factors, which affect these patients; helping patients increase family hardiness, helping patients to positively adapt, and avoid negative coping styles.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: